Northern Trust
FLGT icon

Northern Trust’s Fulgent Genetics FLGT Stock Holding History

Northern Trust’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.9M Buy
182,113
+3,288
+2% +$71.4K ﹤0.01% 2766
2025
Q4 		$4.7M Sell
178,825
-22,001
-11% -$571K ﹤0.01% 2507
2025
Q3 		$4.54M Buy
200,826
+410
+0.2% +$8.44K ﹤0.01% 2558
2025
Q2 		$3.98M Sell
200,416
-853
-0.4% -$16.6K ﹤0.01% 2589
2025
Q1 		$3.4M Sell
201,269
-24,093
-11% -$410K ﹤0.01% 2626
2024
Q4 		$4.16M Buy
225,362
+12,291
+6% +$240K ﹤0.01% 2614
2024
Q3 		$4.63M Sell
213,071
-4,460
-2% -$99.7K ﹤0.01% 2522
2024
Q2 		$4.27M Sell
217,531
-3,497
-2% -$73K ﹤0.01% 2483
2024
Q1 		$4.8M Sell
221,028
-10,368
-4% -$257K ﹤0.01% 2480
2023
Q4 		$6.69M Buy
231,396
+7,588
+3% +$203K ﹤0.01% 2325
2023
Q3 		$5.98M Buy
223,808
+466
+0.2% +$15.9K ﹤0.01% 2335
2023
Q2 		$8.27M Sell
223,342
-1,322
-0.6% -$46.1K ﹤0.01% 2200
2023
Q1 		$7.01M Sell
224,664
-1,261
-0.6% -$40.6K ﹤0.01% 2255
2022
Q4 		$6.73M Buy
225,925
+5,656
+3% +$202K ﹤0.01% 2285
2022
Q3 		$8.4M Sell
220,269
-38,244
-15% -$1.92M ﹤0.01% 2108
2022
Q2 		$14.1M Buy
258,513
+38,851
+18% +$2.14M ﹤0.01% 1773
2022
Q1 		$13.7M Sell
219,662
-40,926
-16% -$2.69M ﹤0.01% 1941
2021
Q4 		$26.2M Buy
260,588
+1,134
+0.4% +$99.7K ﹤0.01% 1579
2021
Q3 		$23.3M Buy
259,454
+101,391
+64% +$9.22M ﹤0.01% 1684
2021
Q2 		$14.6M Sell
158,063
-28,199
-15% -$2.25M ﹤0.01% 2113
2021
Q1 		$18M Buy
186,262
+1,163
+0.6% +$120K ﹤0.01% 1899
2020
Q4 		$9.64M Buy
185,099
+35,402
+24% +$1.48M ﹤0.01% 2266
2020
Q3 		$5.99M Sell
149,697
-2,040
-1% -$63.9K ﹤0.01% 2411
2020
Q2 		$2.43M Buy
151,737
+123,253
+433% +$1.89M ﹤0.01% 2937
2020
Q1 		$306K Sell
28,484
-26
-0.1% -$362 ﹤0.01% 3569
2019
Q4 		$368K Buy
28,510
+11,287
+66% +$134K ﹤0.01% 3633
2019
Q3 		$179K Buy
+17,223
New +$163K ﹤0.01% 3791
2017
Q2 		– Sell
-31,248
Closed -$342K – 4283
2017
Q1 		$342K Buy
31,248
+13,738
+78% +$162K ﹤0.01% 3635
2016
Q4 		$203K Buy
+17,510
New +$165K ﹤0.01% 3762

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Northern Trust's FLGT Position: Q1 2026 in Review

Northern Trust increased its Fulgent Genetics (FLGT) stake by 1.8% in Q1 2026, buying an estimated $71.4K and bringing the position to 182,113 shares worth $2.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2766.

Northern Trust first reported a position in FLGT in Q4 2016 and has held it in 29 quarters since. The position peaked at $26.2M in Q4 2021. 157 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • Northern Trust held 182,113 shares of Fulgent Genetics worth $2.9M as of Q1 2026.
  • Northern Trust bought 3,288 Fulgent Genetics shares in Q1 2026, an estimated $71.4K.
  • Fulgent Genetics made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #2766 holding.
  • Northern Trust first reported a position in Fulgent Genetics in Q4 2016 and has held it in 29 quarters since.
  • Northern Trust's Fulgent Genetics position peaked at $26.2M in Q4 2021.
  • 157 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.